Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease

Journal of Allergy and Clinical Immunology(2022)10.1016/j.jaci.2022.04.007Source: DataRank Database

Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease is a research paper published in Journal of Allergy and Clinical Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 77 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access77 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 11.22)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Aaqib Sohail ORCID,Jonathan Hacker,Rie Maurer ORCID,Deborah Gakpo,Jillian C. Bensko ORCID

Live enrichment

PubMed:35460728 PMC:PMC9378638 OpenAlex:https://openalex.org/W4224250187

NIDDK NIH HHS

Grant: P30 DK034854

NHLBI NIH HHS

Grant: R01 HL128241

NIAID NIH HHS

Grant: K23 AI139352

NIAID NIH HHS

Grant: U19 AI095219

NIAID NIH HHS

Grant: T32 AI007306

Regeneron Pharmaceuticals Inc

American Gastroenterological Association Research Foundation

National Institutes of Health

FWCI

11.22

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9378638

publisherhttps://api.elsevier.com/content/article/PII:S0091674922005425?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674922005425?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaci.2022.04.007

Fields of Study

Drug-Induced Adverse ReactionsSinusitis and nasal conditionsAsthma and respiratory diseasesAspirinAsthma, Aspirin-InducedChronic DiseaseEicosanoidsHumansNasal PolypsProstaglandinsRhinitisSinusitis

MeSH Terms

AspirinChronic DiseaseHumansNasal PolypsProstaglandinsRhinitisSinusitisEicosanoidsAsthma, Aspirin-Induced

Keywords

DupilumabMedicineAspirinRespiratory systemDiseaseIntensive care medicineInternal medicineAsthmaIL-4IL-13AnosmiaNasal PolypAspirin-exacerbated Respiratory DiseaseProstaglandin E(2)AerdLeukotriene E(4)Il-4rα

Sustainable Development Goals

SDG 0: Good health and well-being